Cannara Biotech Inc. (TSX:LOVE)

Canada flag Canada · Delayed Price · Currency is CAD
1.870
+0.030 (1.63%)
At close: Mar 4, 2026
Market Cap184.72M +69.8%
Revenue (ttm)112.25M +28.5%
Net Income11.81M +77.9%
EPS0.12 +61.6%
Shares Out98.78M
PE Ratio15.69
Forward PE13.05
Dividendn/a
Ex-Dividend Daten/a
Volume21,270
Average Volume50,582
Open1.840
Previous Close1.840
Day's Range1.820 - 1.880
52-Week Range1.060 - 2.070
Beta0.34
RSI54.14
Earnings DateApr 24, 2026

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. [Read more]

Industry Pharmaceutical Preparations
Founded 2017
Employees 452
Stock Exchange Toronto Stock Exchange
Ticker Symbol LOVE
Full Company Profile

Financial Performance

In fiscal year 2025, Cannara Biotech's revenue was 107.20 million, an increase of 31.14% compared to the previous year's 81.75 million. Earnings were 13.08 million, an increase of 103.09%.

Financial Statements